Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
- 1Child Health Department, University Hospital of Ioannina, Medical School of Ioannina, Ioannina, Greece
- 2Allergy Unit of the 3rd Pediatric Department, Aristotle University of Thessaloniki, Ioannina, Greece
- 3Amaliada Hospital Unit, General Hospital of Ilias, Amaliada, Ioannina, Greece
- 4Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom
- 5Allergy Department, University Hospitals South Manchester NHS Trust, Manchester, United Kingdom
A corrigendum on
In the original article [Contraindications], paragraph 6, line 159, there was an error. The phrase “Furthermore, well-controlled asthma, regardless of its severity, is not a contradiction for AIT,” was contradicting other assertions in the “contraindications” paragraph. The following sentence should be disregarded: [Furthermore, well-controlled asthma, regardless of its severity, is not a contradiction for AIT (36).]
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: subcutaneous immunotherapy, sublingual immunotherapy, children, allergy, asthma
Citation: Tsabouri S, Mavroudi A, Feketea G and Guibas GV (2017) Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children. Front. Pediatr. 5:187. doi: 10.3389/fped.2017.00187
Received: 25 April 2017; Accepted: 15 August 2017;
Published: 11 September 2017
Edited by:Carlo Caffarelli, University of Parma, Italy
Reviewed by:George N. Konstantinou, 424 Military Medical Training Hospital, Greece
Elisabetta Calamelli, Università di Bologna, Italy
Copyright: © 2017 Tsabouri, Mavroudi, Feketea and Guibas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sophia Tsabouri, firstname.lastname@example.org